[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352811-105":59,"doc-detail-352811-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","a-feeder-cell-free-system-for-chimeric-antigen-receptor-gene-transduction-into-natural-killer-cells","A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells","","Anti-CD19 chimeric antigen receptor (CAR)-natural killer (NK) cells are designed to target relapsed and refractory B-cell malignancies and autoimmune diseases with CAR-T-like activity, while aiming for fewer adverse events and enabling allogeneic use. Current protocols for manufacturing CAR-NK cells are still evolving. This protocol expands NK cells from adult peripheral blood mononuclear cells using CD2- and NKp46-specific antibodies plus multiple cytokines, then performs retroviral gene transfer to generate large-scale anti-CD19 CAR-NK cells without feeder cells, reducing tumor contamination risk.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-feeder-cell-free-system-for-chimeric-antigen-receptor-gene-transduction-into-natural-killer-cells/352811/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-feeder-cell-free-system-for-chimeric-antigen-receptor-gene-transduction-into-natural-killer-cells/352811.png","ImageObject",300,407,{"name":92,"@type":93},"Fahsai","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this protocol for CAR-NK cell generation?","Question",{"text":112,"@type":113},"To expand and genetically modify anti-CD19 CAR-NK cells at scale without feeder cells, enabling safer clinical use.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How are NK cells expanded in this feeder-free method?",{"text":117,"@type":113},"NK cells are selectively expanded from unsorted adult peripheral blood mononuclear cells using CD2- and NKp46-specific stimulatory antibodies together with multiple cytokines.",{"name":119,"@type":110,"acceptedAnswer":120},"How is the CAR gene introduced into the activated NK cells?",{"text":121,"@type":113},"A retroviral vector is used to mediate gene transfer into the stimulated NK cells, followed by additional culture to yield anti-CD19 CAR-NK cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352811,1790821012,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells  \nNobuhiro Kubo 1, §, Minori Baba1, Yuko Suzuki1, 2, Yasushi Kasahara1, Ryosuke Hosokai1, Masaru Imamura1, Akihiko Saitoh 1 and Chihaya Imai1, 3, *  \n1Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan 2CURED, Inc., Kumamoto, Japan  \n3Department of Pediatrics, Faculty of Medicine, University of Toyama, Toyama, Japan  \n*For correspondence: [chihaya@med.u-toyama.ac.jp](chihaya@med.u-toyama.ac.jp)  \n§Technical [contact:](contact: nkubo@med.niigata-u.ac.jp)[ ](contact: nkubo@med.niigata-u.ac.jp)[nkubo@med.niigata-u.ac.jp](contact: nkubo@med.niigata-u.ac.jp)  \nAbstract  \nAnti-CD19 chimeric antigen receptor (CAR)-natural killer (NK) cells are expected to demonstrate anti-CD19 CAR-T-celllike efficacy against relapsed and refractory B-cell malignancies and autoimmune diseases, with fewer adverse events and the added advantage of permitting the use of allogeneic cells. However, the methodology for generating CAR-NK cells remains under development. Although various cell sources and expansion methods are available, feeder cells derived from cancerous tissue have been most commonly employed to promote ex vivo expansion of NK cells. In the protocol described herein, NK cells are expanded from adult peripheral blood mononuclear cells using CD2-and NKp46-specific stimulating antibodies in combination with multiple cytokines. The activated NK cells can be genetically modified using a retroviral vector. Subsequent culture of these cells yields large numbers of anti-CD19 CAR-NK cells. The current method, which enables feeder-free, large-scale generation of anti-CD19 CAR-NK cells, eliminates the risk of tumor cell contamination and may facilitate safer clinical application.  \nKey features  \n• This method for expanding human primary NK cells ex vivo uses stimulatory antibodies and multiple cytokines, without requiring feeder cells, usually derived from cancerous tissue.  \n• NK cells are selectively expanded from unsorted peripheral blood mononuclear cells.  \n• Retroviral vector efficiently mediates gene transfer into NK cells stimulated with the current method.  \n• Although the cells were not sorted, gene transfer into T cells is minimal.  \nKeywords: NK cell expansion, CAR-NK cells, Anti-NKp46 antibody, Anti-CD2 antibody, Interleukin-12, Interleukin-18, Interleukin-21, Off-the-shelf  \nThis protocol is used in: Biomed Pharmacother (2025), DOI: 10.1016/j.biopha.2025.118505  \nGraphical overview  \nSchematic overview of the generation of chimeric antigen receptor (CAR)-natural killer (NK) cells. Peripheral blood mononuclear cells are collected and stimulated with anti-CD2 and anti-NKp46 stimulatory antibodies in the presence of interleukin (IL)-2, IL-12, IL-18, and IL-21. Cells are cultured in medium supplemented with cytokines, and gene transfer is performed using retroviral vectors after 6 days. The cells are then further cultured under the same conditions to generate CAR-NK cells.  \nBackground  \nExtensive research continues to establish immune cell therapy as a treatment option for patients with recurrent and/or refractory malignant tumors. This approach has already been realized for certain types of blood cancers and sarcomas. AntiCD19 chimeric antigen receptor (CAR)-T cells have demonstrated dramatic efficacy against B-cell malignancies [1] . In recent years, anti-CD19 CAR-T cells have also been reported to show promising results in patients with autoimmune diseases, in addition to their use in malignant tumors [2]. Because of allogeneic reactivity, the cell source is typically limited to the patient’s own cells. This approach carries several problems. Insufficient number and poor fitness of T cells collected from heavily treated patients with multiple lines of anti-cancer chemotherapy can result in manufacturing failure [3] . Also, during manufacturing time, which sometimes requires more tha","cbCaifW83NQd35VT","https://ap.wps.com/l/cbCaifW83NQd35VT","pdf",5579544,13,"English","# Abstract\n# Key features\n# Keywords\n# Background\n# Graphical overview","[{\"question\":\"What is the main goal of this protocol for CAR-NK cell generation?\",\"answer\":\"To expand and genetically modify anti-CD19 CAR-NK cells at scale without feeder cells, enabling safer clinical use.\"},{\"question\":\"How are NK cells expanded in this feeder-free method?\",\"answer\":\"NK cells are selectively expanded from unsorted adult peripheral blood mononuclear cells using CD2- and NKp46-specific stimulatory antibodies together with multiple cytokines.\"},{\"question\":\"How is the CAR gene introduced into the activated NK cells?\",\"answer\":\"A retroviral vector is used to mediate gene transfer into the stimulated NK cells, followed by additional culture to yield anti-CD19 CAR-NK cells.\"}]","A Feeder Cell-Free System for Chimeric Antigen Receptor Gene Transduction Into Natural Killer Cells | PDF",1790101484,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/809a45344f7efede30b324b76128895f.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/036325cbd23af30e8e686aee8ef49083.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e4654862967ee8008a7a3fd144ad115f.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/60e3fc90247ddde82a6384d7e93dcf2f.webp",980,1385]